I-Tirzepatide CAS:2023788-19-2 Umkhiqizi Umhlinzeki Isithombe Esivelele

I-Tirzepatide CAS:2023788-19-2 Umhlinzeki Womkhiqizi

I-Tirzepatide yathuthukiswa njenge-agonist ephindwe kabili kuma-receptor e-GLP-1 kanye ne-gastric inhibitory polypeptide (GIP) (Frias et al., 2018). Ngokufanayo ne-GLP-1, i-GIP iyi-hormone ye-incretin esebenza ukukhuthaza ukukhishwa kwe-insulin. I-Tirzepatide isesigabeni sesi-3 sokuthuthukiswa kwabantu abadala abanokukhuluphala noma abakhuluphele abanezifo ezihlobene nesisindo futhi okwamanje ingaphansi kokubuyekezwa komthetho njengokwelashwa kwabantu abadala abanesifo sikashukela sohlobo lwe-2. Iphinde ifundwe njengokwelashwa okungenzeka kwe-steatohepatitis engeyona utshwala (NASH) kanye nokwehluleka kwenhliziyo nge-preserved ejection fraction (HFpEF).

Oda noma Cela Isilinganiso

Imininingwane Yomkhiqizo

Amathegi Omkhiqizo

Ukusetshenziswa kanye Nomphumela

I-Tirzepatide isetshenziswa nohlelo lokudla olufanele kanye nokuzivocavoca ukulawula ushukela wegazi ophezulu kubantu abanesifo sikashukela sohlobo 2. Ukulawula ushukela wegazi ophezulu kusiza ukuvimbela ukulimala kwezinso, ubumpumputhe, izinkinga zemizwa, ukulahlekelwa yizitho zomzimba, kanye nezinkinga zokusebenza kocansi. I-Tirzepatide inamathele kakhulu kuma-receptor e-GIP kunama-receptor e-GLP-1, futhi lokhu kuziphatha kwe-agonist okubili kuboniswe ukuthi kunciphisa kakhulu i-hyperglycemia uma kuqhathaniswa ne-agonist ye-receptor ye-GLP-1 ekhethiwe. Izifundo zokubonisa izimpawu zikhombisile ukuthi lokhu kungenxa yokuthi i-tirzepatide ilingisa izenzo ze-GIP yemvelo kuma-receptor e-GIP.

Isampula Yomkhiqizo

Ukupakisha Umkhiqizo:

Ulwazi Olwengeziwe:

Ukwakheka	Na
Ukuhlolwa	99%
Ukubukeka	Impuphu emhlophe
Inombolo ye-CAS	2023788-19-2
Ukupakisha	25KG
Impilo Yeshelufu	iminyaka engu-2
Isitoreji	Gcina endaweni epholile neyomile
Isitifiketi	I-ISO.